Ulcerative colitis - The Lancet
New Drugs in the Ulcerative Colitis Pipeline: Prometheus Unbound - Gastroenterology
Mechanism of vedolizumab. This image is modified from their original... | Download Scientific Diagram
Cureus | Efficacy and Safety of Vedolizumab in Management of Moderate to Severe Ulcerative Colitis: A Systematic Review
The potential mechanism of Bawei Xileisan in the treatment of dextran sulfate sodium-induced ulcerative colitis in mice - ScienceDirect
Mechanism of vedolizumab. This image is modified from their original... | Download Scientific Diagram
Deciphering the vedolizumab dosing conundrum in IBD: when less is more | Gut
Mechanism of vedolizumab. This image is modified from their original... | Download Scientific Diagram
Vedolizumab targets the α4β7 integrin, preventing leucocyte... | Download Scientific Diagram
Identification of an Anti–Integrin αvβ6 Autoantibody in Patients With Ulcerative Colitis - Gastroenterology
Vedolizumab for the treatment of ulcerative colitis and Crohn's disease | Immunotherapy
Upadacitinib for Crohn's Disease and Ulcerative Colitis Treatment: Hitting the Selective JAKpot - Gastroenterology
Classes of Biologics for the Treatment of IBD - ALPCO
Mechanism of Action | Entyvio® (vedolizumab)
Inflammatory colonic carcinogenesis: A review on pathogenesis and immunosurveillance mechanisms in ulcerative colitis
Vedolizumab Overview - Creative Biolabs
Vedolizumab for inflammatory bowel disease: From randomized controlled trials to real-life evidence
Small molecule oral targeted therapies in ulcerative colitis - The Lancet Gastroenterology & Hepatology
Integrated bioinformatics and network pharmacology to identify the therapeutic target and molecular mechanisms of Huangqin decoction on ulcerative Colitis | Scientific Reports
Mechanism of Action | Entyvio® (vedolizumab)
A mechanism of action of vedolizumab. | Download Scientific Diagram
Nutritional modulators of ulcerative colitis: Clinical efficacies and mechanistic view
The current state of the art for biological therapies and new small molecules in inflammatory bowel disease | Mucosal Immunology
Vedolizumab: Uses, Interactions, Mechanism of Action | DrugBank Online
Etrolizumab for the Treatment of Ulcerative Colitis and Crohn's Disease: An Overview of the Phase 3 Clinical Program | SpringerLink
